Product Program year 2025 Source: CMS Open Payments

General - Therapies

Device General - Therapies_IC

Open in the dashboard

General payments

$1,644,109

4,062 payments

Research payments

$0

0 payments

Through program year 2025, $1,644,109 in general payments and $0 in research payments were reported against General - Therapies (General - Therapies_IC).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $831,047 1,990
2022 General $813,062 2,072

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $1,644,109 4,062 payments
Top recipients General payments · program year 2025
  1. Taisei Kobayashi Interventional Cardiology · Philadelphia, PA $204,641 25% · 2 payments
  2. Lewis Rubin Internal Medicine · La Jolla, CA $138,782 17% · 1 payment
  3. Eric Secemsky Interventional Cardiology · Boston, MA $133,732 16% · 2 payments
  4. Gregory Lewis Cardiovascular Disease · Boston, MA $73,179 9% · 1 payment
  5. Washington Hospital Center Teaching hospital · DC $50,000 6% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $416,470 54% · 450 practitioners
  2. Internal Medicine $196,257 25% · 74 practitioners
  3. Cardiovascular Disease Internal Medicine $125,053 16% · 244 practitioners
  4. Clinical Cardiac Electrophysiology Internal Medicine $10,600 1% · 85 practitioners
  5. Endocrinology, Diabetes & Metabolism Internal Medicine $6,000 <1% · 1 practitioner

The top 5 of 53 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Massachusetts $219,845 26% · 20 recipients
  2. Pennsylvania $211,527 25% · 32 recipients
  3. California $161,119 19% · 133 recipients
  4. Illinois $55,134 7% · 16 recipients
  5. District of Columbia $53,310 6% · 5 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

4,062 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record